In this study, we investigated whether HS201-PDT monotherapy or the combination with anti-PD-L1 can inhibit DCIS progression to invasive BC using multiple DCIS models, including human DCIS orthotopic xenograft models and spontaneous BC models in transgenic mice. Here, CD274 is linked to ductal breast carcinoma in situ.